GLP-1 receptor agonists, CKD, and eGFR trajectory

Research output: Contribution to journal › Comment/Letter to the editor › Academic

6 Citations (Scopus)

Original language	English
Pages (from-to)	764-765
Number of pages	2
Journal	LANCET DIABETES & ENDOCRINOLOGY
Volume	6
Issue number	10
DOIs	https://doi.org/10.1016/S2213-8587(18)30241-9
Publication status	Published - 2018

Access to Document

@article{03f48a91d97f4926873bac70f52f5d5b,

title = "GLP-1 receptor agonists, CKD, and eGFR trajectory",

author = "{van Baar}, {Micha{\"e}l J. B.} and {van Raalte}, {Dani{\"e}l H.} and Muskiet, {Marcel H. A.}",

year = "2018",

doi = "https://doi.org/10.1016/S2213-8587(18)30241-9",

language = "English",

volume = "6",

pages = "764--765",

journal = "LANCET DIABETES & ENDOCRINOLOGY",

issn = "2213-8587",

publisher = "Elsevier BV",

number = "10",

}

TY - JOUR

T1 - GLP-1 receptor agonists, CKD, and eGFR trajectory

AU - van Baar, Michaël J. B.

AU - van Raalte, Daniël H.

AU - Muskiet, Marcel H. A.

PY - 2018

Y1 - 2018

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85053806160&origin=inward

U2 - https://doi.org/10.1016/S2213-8587(18)30241-9

DO - https://doi.org/10.1016/S2213-8587(18)30241-9

M3 - Comment/Letter to the editor

C2 - 30266180

SN - 2213-8587

VL - 6

SP - 764

EP - 765

JO - LANCET DIABETES & ENDOCRINOLOGY

JF - LANCET DIABETES & ENDOCRINOLOGY

IS - 10

ER -